Guardian Pharmacy Services Valuation Multiples

Guardian Pharmacy Services is valued at $2.6B as of November 2026, a 1.8x revenue multiple. In the last 12 months, Guardian Pharmacy Services revenue was $1.4B and Guardian Pharmacy Services EBITDA was $128M.

Guardian Pharmacy Services Overview

About Guardian Pharmacy Services

Guardian Pharmacy Services Inc is a differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. The company emphasizes high-touch, individualized clinical, drug dispensing, and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as ALFs and BHFs. The operating segment derives its revenues through sales of pharmaceutical and medical products, and all revenues are derived solely in the United States.


Founded

2003

HQ

United States

Employees

3.4K

Financials (LTM)

Revenue: $1.4B
EBITDA: $128M

EV

$2.5B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Guardian Pharmacy Services Financials

Guardian Pharmacy Services reported last 12-month revenue of $1.4B and EBITDA of $128M.

In the same LTM period, Guardian Pharmacy Services generated $325M in gross profit, $128M in EBITDA, and $76M in net income.

Revenue (LTM)


Guardian Pharmacy Services P&L

In the most recent fiscal year, Guardian Pharmacy Services reported revenue of $1.4B and EBITDA of $96M.

Guardian Pharmacy Services is profitable as of last fiscal year, with gross margin of 20%, EBITDA margin of 7%, and net margin of 3%.

See analyst estimates for Guardian Pharmacy Services
LTMLast FY202320242025202620272028
Revenue$1.4B$1.4B$1B$1.2B$1.4B
Gross Profit$325M$293M$208M$244M$293M
Gross Margin23%20%20%20%20%
EBITDA$128M$96M$59M($43M)$96M
EBITDA Margin9%7%6%(4%)7%
EBIT Margin6%5%4%(5%)5%
Net Profit$76M$49M$24M($87M)$49M
Net Margin5%3%2%(7%)3%
Net Debt-($28M)---

Financial data powered by Morningstar, Inc.

Guardian Pharmacy Services Stock Performance

Guardian Pharmacy Services has current market cap of $2.6B, and enterprise value of $2.5B.

Market Cap Evolution


Guardian Pharmacy Services' stock price is $40.87.

Guardian Pharmacy Services share price increased by 0.4% in the last 30 days, and by 39.6% in the last year.

Guardian Pharmacy Services has an EPS (earnings per share) of $0.78.

See more trading valuation data for Guardian Pharmacy Services
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2.5B$2.6B2.2%0.4%10.2%39.6%$0.78

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Guardian Pharmacy Services Valuation Multiples

Guardian Pharmacy Services trades at 1.8x EV/Revenue multiple, and 19.9x EV/EBITDA.

See NTM and 2027E valuation multiples for Guardian Pharmacy Services

EV / Revenue (LTM)


Guardian Pharmacy Services Financial Valuation Multiples

As of November 4, 2026, Guardian Pharmacy Services has market cap of $2.6B and EV of $2.5B.

Guardian Pharmacy Services has a P/E ratio of 34.3x.

LTMLast FY202320242025202620272028
EV/Revenue1.8x1.8x2.4x2.1x1.8x
EV/EBITDA19.9x26.4x43.3x(58.6x)26.4x
EV/EBIT28.6x35.0x62.2x(40.5x)35.0x
EV/Gross Profit7.8x8.7x12.2x10.4x8.7x
P/E34.3x52.6x108.3x(29.7x)52.6x
EV/FCF26.1x31.5x45.3x61.2x31.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Guardian Pharmacy Services Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Guardian Pharmacy Services Margins & Growth Rates

Guardian Pharmacy Services decreased revenue by 0% but EBITDA grew by 35% in the last fiscal year.

In the most recent fiscal year, Guardian Pharmacy Services reported gross margin of 20%, EBITDA margin of 7%, and net margin of 3%.

See estimated margins and future growth rates for Guardian Pharmacy Services

Guardian Pharmacy Services Margins

Last FY202420252026202720282029
Gross Margin20%20%20%23%
EBITDA Margin7%(4%)7%9%
EBIT Margin5%(5%)5%6%
Net Margin3%(7%)3%6%
FCF Margin6%3%6%7%

Guardian Pharmacy Services Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth(0%)17%18%(0%)
Gross Profit Growth13%17%20%13%
EBITDA Growth35%(174%)(322%)35%
EBIT Growth27%(254%)(216%)27%
Net Profit Growth63%(465%)(156%)63%
FCF Growth25%(26%)94%25%

Data powered by FactSet, Inc. and Morningstar, Inc.

Guardian Pharmacy Services Operational KPIs

Guardian Pharmacy Services' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.

Guardian Pharmacy Services' Rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Guardian Pharmacy Services' Rule of X is 8% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Guardian Pharmacy Services
LTMLast FY202320242025202620272028
Rule of 4014%9%---
Bessemer Rule of X22%8%---
Revenue per Employee-$0.4M---
Opex per Employee-$0.1M---
Opex to Revenue-15%16%25%15%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Guardian Pharmacy Services Competitors

Guardian Pharmacy Services competitors include Asker Healthcare Group, Topchoice Medical, Acadia Healthcare, Pediatrix, Meinian Onehealth, Mouwasat, Kpj Healthcare, Surgery Partners, IKS Health and Krishna Institute of Medical Sciences.

Most Guardian Pharmacy Services public comparables operate across Hospitals & Clinics.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Asker Healthcare Group$1.7B$171M1.9x1.7x19.1x13.3x
Topchoice Medical$438M$140M6.0x5.6x18.8x17.7x
Acadia Healthcare$3.3B($738M)1.6x1.6x(7.3x)8.9x
Pediatrix$1.9B$274M1.3x1.3x9.4x8.8x
Meinian Onehealth$1.6B$308M2.3x2.4x11.4x15.3x
Mouwasat$859M$300M3.7x3.4x10.6x10.4x
Kpj Healthcare$1B$257M3.5x3.3x14.3x13.9x
Surgery Partners$3.3B$566M2.6x2.7x15.2x17.2x

This data is available for Pro users. Sign up to see all Guardian Pharmacy Services competitors and their valuation data.

Start Free Trial

Acquisitions by Guardian Pharmacy Services

Guardian Pharmacy Services has acquired 8 companies to date.

Last acquisition by Guardian Pharmacy Services was on November 2nd 2026. Guardian Pharmacy Services acquired Van’s Institutional Pharmacy for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by Guardian Pharmacy Services

Van’s Institutional Pharmacy
Nautilus Pharmacy
Wellness Concepts
Managed Healthcare Pharmacy
Description
Van's Institutional Pharmacy is a long-term care pharmacy based in Martin, Tennessee. It supplies prescription medications to care communities and individual patients, with free delivery. Its services include multi-dose compliance pill packaging, immunizations, stat medication management, prior authorization assistance, and medication adherence and patient counseling. The pharmacy also supports patients with mental health needs and intellectual and developmental disabilities. Revenue comes from dispensing medications and pharmacy services to facilities and individuals.
Nautilus Pharmacy is a pharmacy operator focused on supplying medications to long-term care facilities.
Wellness Concepts is a pharmacy operator focused on long-term care for residents in assisted living facilities, nursing homes, and similar settings.
Managed Healthcare Pharmacy is a pharmacy services provider that enhances patient and population health outcomes through specialized medication management. Based in the United States, the company offers compounding, delivery, and adherence programs tailored for chronic disease patients, partnering with healthcare providers to reduce readmissions and improve therapeutic results.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Martin, TN
Nashville, TN
Grottoes, VA
Eugene, OR
Deal Date2 Nov 20261 Sep 202630 Jun 20264 Aug 2025
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Guardian Pharmacy Services acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Guardian Pharmacy Services

When was Guardian Pharmacy Services founded?Guardian Pharmacy Services was founded in 2003.
Where is Guardian Pharmacy Services headquartered?Guardian Pharmacy Services is headquartered in United States.
How many employees does Guardian Pharmacy Services have?As of today, Guardian Pharmacy Services has over 3K employees.
Who is the CEO of Guardian Pharmacy Services?Guardian Pharmacy Services' CEO is Fred Burke.
Is Guardian Pharmacy Services publicly listed?Yes, Guardian Pharmacy Services is a public company listed on NYSE.
What is the stock symbol of Guardian Pharmacy Services?Guardian Pharmacy Services trades under GRDN ticker.
When did Guardian Pharmacy Services go public?Guardian Pharmacy Services went public in 2024.
Who are competitors of Guardian Pharmacy Services?Guardian Pharmacy Services main competitors include Asker Healthcare Group, Topchoice Medical, Acadia Healthcare, Pediatrix, Meinian Onehealth, Mouwasat, Kpj Healthcare, Surgery Partners, IKS Health, Krishna Institute of Medical Sciences.
What is the current market cap of Guardian Pharmacy Services?Guardian Pharmacy Services' current market cap is $2.6B.
What is the current revenue of Guardian Pharmacy Services?Guardian Pharmacy Services' last 12 months revenue is $1.4B.
What is the current revenue growth of Guardian Pharmacy Services?Guardian Pharmacy Services revenue growth (NTM/LTM) is 5%.
What is the current EV/Revenue multiple of Guardian Pharmacy Services?Current revenue multiple of Guardian Pharmacy Services is 1.8x.
What is the current EBITDA of Guardian Pharmacy Services?Guardian Pharmacy Services' last 12 months EBITDA is $128M.
What is Guardian Pharmacy Services' EBITDA margin?Guardian Pharmacy Services' last 12 months EBITDA margin is 9%.
What is the current EV/EBITDA multiple of Guardian Pharmacy Services?Current EBITDA multiple of Guardian Pharmacy Services is 19.9x.
What is the current FCF of Guardian Pharmacy Services?Guardian Pharmacy Services' last 12 months FCF is $98M.
What is Guardian Pharmacy Services' FCF margin?Guardian Pharmacy Services' last 12 months FCF margin is 7%.
What is the current EV/FCF multiple of Guardian Pharmacy Services?Current FCF multiple of Guardian Pharmacy Services is 26.1x.
How many companies Guardian Pharmacy Services has acquired to date?As of November 2026, Guardian Pharmacy Services has acquired 8 companies.
What was the largest acquisition by Guardian Pharmacy Services?None of the M&A deals Guardian Pharmacy Services has completed have disclosed valuations.
What companies Guardian Pharmacy Services acquired?Guardian Pharmacy Services acquired Mercury Pharmacy Services, Senior Care Pharmacy, Nautilus Pharmacy, Wellness Concepts, Guardian Pharmacy of Anaheim, Managed Healthcare Pharmacy, Pharmacy Concepts, and Van’s Institutional Pharmacy.
In how many companies Guardian Pharmacy Services has invested to date?Guardian Pharmacy Services hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Guardian Pharmacy Services

Lists including Guardian Pharmacy Services

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial